Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:

Wednesday, August 3, 2016

Human Recombinant Hyaluronidase Injections For Upper Limb Muscle Stiffness in Individuals With Cerebral Injury: A Case Series

Having never heard of this before I have zero clue on it. A great stroke association would have complete documentation on it with efficacy and protocols. But we have fucking failures of stroke associations instead.Or is hyaluronan just the aftereffects of contracturre?
1Dr. Preeti Raghavan confirms that she had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Open Access Article has an altmetric score of 4


  • The accumulation of hyaluronan within muscles contributes to the development of muscle stiffness after neurologic injury.
  • Intramuscular injection of hyaluronidase reduces muscle stiffness and increases passive and active movement.
  • The injections did not produce weakness or clinically significant adverse effects in the reported case series.
Muscle stiffness contributes to disability after neurologic injury. However both the cause of the muscle stiffness and its treatment remain to be established. We propose that the accumulation of hyaluronan within muscles promotes the development of muscle stiffness. We report that the enzyme hyaluronidase, which hydrolyzes hyaluronan, reduces muscle stiffness and increases both passive and active movement in individuals with spastic paralysis after cerebral injury. The treatment takes effect within days to 2 weeks, lasts for at least three months, does not produce weakness, and is safe without clinically significant adverse effects. These results present a promising treatment for a widespread problem.


Spasticity, muscle stiffness and contracture cause severe disability after central nervous system injury. However, current treatment options for spasticity produce muscle weakness which can impede movement, and do not directly address muscle stiffness. Here we propose that the accumulation of hyaluronan within muscles promotes the development of muscle stiffness, and report that treatment with the enzyme hyaluronidase increases upper limb movement and reduces muscle stiffness without producing weakness. 20 patients with unilateral upper limb spasticity received multiple intramuscular injections of human recombinant hyaluronidase with saline at a single visit. The safety and efficacy of the injections, passive and active movement, and muscle stiffness at eight upper limb joints were assessed at four time points: pre-injection (T0), within 2 weeks (T1), within 4–6 weeks (T2), and within 3–5 months post-injection (T3). There were no clinically significant adverse effects from the injections. Passive movement at all joints, and active movement at most joints increased at T1, and persisted at T2 and T3 for most joints. The modified Ashworth scores also declined significantly over time post-injection. Hyaluronidase injections offer a safe and potentially efficacious treatment for muscle stiffness in neurologically impaired individuals. These results warrant confirmation in placebo-controlled clinical trials.

No comments:

Post a Comment